Active Ingredient Afatinib Dimaleate

Active Ingredient Details

What is Afatinib Dimaleate?

A quinazoline and butenamide derivative that acts as a tyrosine kinase inhibitor of epidermal growth factor receptors (ERBB RECEPTORS) and is used in the treatment of metastatic NON-SMALL CELL LUNG CANCER.

What is the usage for Afatinib Dimaleate?

Afatinib is used to treat a certain type of lung cancer (non-small cell lung cancer). It belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. It binds to a certain protein (epidermal growth factor receptor-EGFR) in some tumors.

How many products in the NDC database contain Afatinib Dimaleate?

The NDC database has 4 products with the active ingredient Afatinib Dimaleate. The following table lists all the products that have this active ingredient.

NDC Products with Afatinib Dimaleate

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
46708-895Proprietary Name: Afatinib DimaleatePowderAlembic Pharmaceuticals LimitedACTIVE
54893-0054Proprietary Name: Afatinib DimaleatePowderMsn Laboratories Private LimitedACTIVE
63592-0355Proprietary Name: Afatinib DimaleatePowderSicor De Mexico S.a. De C.vACTIVE
68554-0107Proprietary Name: Afatinib DimaleatePowderHetero Labs LimitedACTIVE